News and Resources > Latest News
Researchers Identify Toxic Mushroom-Based Drug To Fight Colorectal Cancer
A toxin called alpha-amanatin, derived from “death cap” mushrooms was considered for some time as a potential treatment for colorectal cancer. But since the toxin is known to cause liver toxicity, there have been limitations to enable its use as a potential effective therapy.
In a recent study published in Nature, a team of researchers at The University of Texas MD Anderson Cancer Center led by Xiongbin Lu, Ph.D., associate professor of Cancer Biology investigated the alpha-amanatin derived antibody drug conjugates (ADCs) as one potential solution.
- Bowel cancer risk may be reduced by rural African diet, study finds
- Cancer survival rates on the rise, U.S. analysis finds
- Novel Biomarkers for Colorectal Cancer Detection Discovered
- Which foods are known to reduce bowel cancer risk?
- A New Cold Plasma Apparatus To Kill Cancer Cells In Colon Cancer
- Dietary supplements linked to increased cancer risk
- Exercise is Beneficial for Colorectal Cancer Survivors, According to Study
- New Blood Test Shows Promise in Cancer Fight
- A Vaccine May Aid Colon Cancer Prevention in the Future
- Exercise for Cancer Patients: Fitness After Treatment
- Researchers Target Protein To Stop Spread Of Colon Cancer
- Pancreatic Cancer Drug Works Against Accumulation of Malignant Ascites Fluid in Colon Cancer Patients
- News Archives